2026 / 05 / 13
We’re attending at
TIDES USA 2026
Ajinomoto Bio-Pharma Services will participate in TIDES USA 2026, on May 11 to 14, 2026.
TIDES USA is the Industry’s largest & most renowned event to accelerate Oligo and Peptide Therapeutics to market, and to leading strategies for expediting R&D and improving CMC efficiency.
Ajinomoto Bio-Pharma Services will be making the oral presentation about RNA at the conference.
We look forward to your visit.
| Event Name | TIDES USA 2026 |
|---|---|
| Dates | May 11 (Mon) – 14 (Thu), 2026 |
| Venue | Hynes Convention Center Boston, MA, USA |
Oral Presentation
| Title and Presenters | Unlocking Scalable and Process-Efficient Oligonucleotide Manufacturing: AJIPHASE and Enzymatic Ligation |
|---|---|
| Abstract | As oligonucleotide therapeutics expand into broader indications, demand is increasing rapidly. However, conventional manufacturing faces limitations in efficiency, sustainability, and scalability. Ajinomoto Bio-Pharma Services is developing innovative solutions to address these challenges. Our liquid-phase synthesis platform, AJIPHASE, provides a scalable approach with improved process efficiency, In addition, enzymatic ligation enables high-purity siRNA production. This presentation highlights recent progress and their impact on efficient, large-scale manufacturing. |
| Date, Time and Venue | May 13(Wed), 2026 7:45 AM |